Experimental Drug For Near-Terminal Leukemia Patients Raises Hope
Acute myeloid leukemia is the most common blood cancer in adults, with 120,000 cases new cases being diagnosed every year. Unfortunately, the three-year survival rate is just 25% for the disease.
Read Original Article: Experimental Drug For Near-Terminal Leukemia Patients Raises Hope »
